CRISPR-based gene therapies represent a potentially transformative treatment modality for patients suffering from diseases with underlying genetic etiologies. However, utilizing this knowledge to improve human health requires both scientific innovation and industrial translation of these ideas into treatments. As a PhD candidate in the Doudna lab, I have strived to not only develop a solid scientific foundation, but to learn about the development landscape for novel treatment modalities. From a high school research internship to my current position as a PhD candidate, I have grown into a strong and confident scientist. After graduating, my career aspirations are to become an industry leader in developing intracellular biologics. I believe that the technical and professional skills I gain from my graduate research will provide me a foundation for a successful career in early-stage industrial development of cutting edge biotherapeutics.
Hannah Karp
